Skip to content

menu

Proskauer Rose LLP logo
HomeAboutSubscribeCurrent Page:TopicsContact
Search
Close

Proskauer in Life Sciences

Developments and trends in therapeutics, pharmaceuticals, biotechnology and medical devices

Topics

Biopharmaceuticals

The Seventh Circuit Asks, “What’s Wrong With Having Lots of Patents?”BridgeBio Transaction Reflects Healthy Market for FDA Priority Review Vouchers“Negative” Patent Claim Limitations—May They be Adequately Described by Omission?

Biosimilars

The Seventh Circuit Asks, “What’s Wrong With Having Lots of Patents?”BridgeBio Transaction Reflects Healthy Market for FDA Priority Review VouchersPreparing for Europe’s Unified Patent Court

Biotechnology

Update on Artificial Intelligence: USPTO Urges Federal Circuit to Affirm Decision That AI Cannot Qualify as an “Inventor”Preparing for Europe’s Unified Patent CourtSkinny Labels May Not Be Dead: Delaware District Court Distinguishes GSK, Dismisses Induced Infringement Claim

Diagnostics

In the Orphan Drug Approval Race, Winner Takes All? Ramifications of Catalyst Pharms. v. BecerraSynthetic Data Gets Real

Medical Devices

U.S. Medical Device Manufacturers Should Take Note of New European Medical Device RegulationsPrior Art Showing An Invention To Be “At Least Possible” Found Sufficient To Invalidate Surgical Device PatentFederal Circuit Invalidates Device Patent As Directed to an Abstract Idea

Therapeutics

BridgeBio Transaction Reflects Healthy Market for FDA Priority Review VouchersUpdate on Artificial Intelligence: USPTO Urges Federal Circuit to Affirm Decision That AI Cannot Qualify as an “Inventor”Preparing for Europe’s Unified Patent Court

Stay Connected

RSS LinkedIn Facebook Twitter Instagram

Editors

Photo of Colin G. CabralColin G. CabralPartner
Photo of Robert A. CantoneRobert A. CantonePartner
Photo of Fangli ChenFangli ChenPartner
Photo of Daryn GrossmanDaryn GrossmanPartner
Photo of Siegmund Y. GutmanSiegmund Y. GutmanPartner
Photo of Baldassare VintiBaldassare VintiPartner and Head, Intellectual Property Litigation Group

Blog Authors Show/Hide

  • James Anderson
  • Colin G. Cabral
  • Robert A. Cantone
  • Fangli Chen
  • Tamaria Dewdney
  • Christine G. Espino
  • Lawrence Frank
  • Russell T. Gorkin
  • Daryn Grossman
  • Siegmund Y. Gutman
  • David Michael Hanna
  • Michelle M. Ovanesian
  • Nicholas C. Prairie
  • William C. Rose
  • Anisha Shenai-Khatkhate
  • Gourdin Sirles
  • Baldassare Vinti
  • Hena M. Vora

Topics

Archives

Proskauer in Life Sciences

View All Proskauer Blogs
Proskauer Rose LLP logo
Beijing|Boca Raton|Boston|Chicago|Hong Kong|London|Los Angeles|New Orleans|New York|Paris|São Paulo|Washington, DC
RSS LinkedIn Facebook Twitter Instagram
DisclaimerPrivacy Policy

About Proskauer Rose LLP

We are 800+ lawyers serving clients from offices located in the leading financial and business centers in the Americas, Europe and Asia. The world’s leading organizations, companies and corporations choose us to be their representatives in their most critical situations. Moreover, they consider Proskauer a strategic partner to drive their business forward. We work with asset managers, private equity and venture capital firms, Fortune 500 companies, major sports leagues, entertainment industry legends and other industry-redefining companies.

Visit Proskauer.com

Copyright ©2023, Proskauer Rose LLP. All Rights Reserved.
Law blog design & platform by LexBlog LexBlog Logo

This website uses third party cookies, over which we have no control. To deactivate the use of third party advertising cookies, you should alter the settings in your browser.

OK